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Tumor suppressor Nf2/merlin drives Schwann cell changes
following electromagnetic ﬁeld exposure through
Hippo-dependent mechanisms
A Colciago1, S Melﬁ1, G Giannotti, V Bonalume, M Ballabio, L Cafﬁno, F Fumagalli and V Magnaghi
Previous evidence showed mutations of the neuroﬁbromin type 2 gene (Nf2), encoding the tumor suppressor protein merlin, in
sporadic and vestibular schwannomas affecting Schwann cells (SCs). Accordingly, efforts have been addressed to identify possible
factors, even environmental, that may regulate neuroﬁbromas growth. In this context, we investigated the exposure of SC to an
electromagnetic ﬁeld (EMF), which is an environmental issue modulating biological processes. Here, we show that SC exposed to
50 Hz EMFs changes their morphology, proliferation, migration and myelinating capability. In these cells, merlin is downregulated,
leading to activation of two intracellular signaling pathways, ERK/AKT and Hippo. Interestingly, SC changes their phenotype toward
a proliferative/migrating state, which in principle may be pathologically relevant for schwannoma development.
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INTRODUCTION
Neuroﬁbromin 2 gene (Nf2) encodes the tumor suppressor protein
merlin, a cytoskeleton-associated protein belonging to the ERM
(ezrin-radixin-moesin) family. Mutations in the Nf2 gene origin an
autosomal dominant multiple syndrome called neuroﬁbromatosis
type 2,1 leading to merlin loss and determining the transformation
of Schwann cells (SCs) into a form of benign tumor called
schwannoma. About 5% of vestibular schwannomas (which are
neuroﬁbromas originating from the SC of the eighth cranial
vestibular nerve) are related to inherited Nf2 mutations, whereas
the remaining 95% are sporadic.2 Indeed, between 30 and 50% of
new cases arise by random genetic mutations.3 However, merlin is
mutated at least in 66% of sporadic schwannomas indicating a
correlation between this protein and tumor development.4
Recent research on Nf2 gene showed that merlin is involved in
different signal transduction pathways, including MAPK/ERK and
Hippo pathways.5,6 Indeed, in merlin null schwannomas the
MAPK/ERK pathway is activated,6 whereas the Hippo pathway is
involved in several cell transformations,7 mostly through control
of the transcriptional co-activator Yes-associated protein (Yap).8
Of note, Hippo has been indicated as a major effector of merlin in
growth regulation,9 even though this correlation was poorly
investigated in SCs.
In the last years, some efforts have been addressed to
determine possible factors, even environmental, that may regulate
neuroﬁbromas growth. In this context, the exposure to electro-
magnetic ﬁelds (EMFs) is an environmental issue modulating
biological processes in different type of cells. EMF emissions yield
changes in migration, cytoskeleton organization, ion channels
regulation and oxidative balance.10–13 Some epidemiologic
studies indicate a consistent risk for the occurrence of neurode-
generative diseases and different tumors,14 including schwanno-
mas, in subjects exposed to EMFs. Data from clinical case–control
studies corroborate this pathogenic correlation.15–18 Nevertheless,
EMF is used in clinic to treat different pathologic conditions,
indeed the therapeutic use of low-frequency (20 Hz) EMFs has
long been proposed as a reliable tool to promote re-myelination
and peripheral nerve regeneration.19–21 However, variable biologic
responses to the different frequency exposures have been
hypothesized. Mechanisms correlating the EMF exposure to the
biological changes in SC, likely to the onset of schwannomas and
the possible alterations in merlin, were far to be elucidated.
The aim of the present study was to investigate whether the
tumor suppressor merlin may regulate cellular and biochemical
features, such as morphology, viability, proliferation, and myeli-
nating capability of SC exposed to EMFs. Our results showed that
EMF at higher frequency (50 Hz) regulates SCs phenotype and
likely affects their pathophysiologic condition, by activation of
ERK/AKT and Hippo signaling pathways.
RESULTS
Exposure to EMF induces changes in SCs morphology and
proliferation
SCs primary cultures from 3-day-old rats were used for the
experiments. These cells showed the characteristic spindle-shape
morphology in vitro. Cell purity, more than 98%, was assessed
performing immunolabeling for the typical markers myelin protein
zero (P0) and protein S100 (Figure 1a). To test the effects of EMF
on SC biological features, we applied an EMF intensity of 50 Hz,
0.1T for 10 min (Figure 1b). EMF exposure induced morphologic
rearrangements in actin cytoskeleton, which might be critical for
SCs differentiation and myelination. SCs turn from a spindle-
shaped to an enlarged phenotype, indicating a dysregulation in
the differentiation program; in fact, cells exposed to the treatment
resemble to the undifferentiated phenotype (Figure 1c).
Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via G. Balzaretti 9, Milan 20133, Italy.
Correspondence: V Magnaghi (valerio.magnaghi@unimi.it)
1These authors contributed equally to this work and may be both considered as ﬁrst authors.
Received 9 July 2015; accepted 10 July 2015; Edited by A Ruﬁni
Citation: Cell Death Discovery (2015) 1, 15021; doi:10.1038/cddiscovery.2015.21
© 2015 Cell Death Differentiation Association All rights reserved 2058-7716/15
www.nature.com/cddiscovery
We next evaluated the effects of EMFs on cell proliferation to
test whether EMF exposure may yield other SCs biological
changes. Speciﬁcally, SCs count was evaluated in vitro at 6, 24,
48 and 72 h following EMF exposure (Figure 1d). The effect already
present after 24 h became signiﬁcantly evident at longer times, 48
and 72 h (Po0.05). Noteworthy, a second EMF exposure after 24 h
strongly increases SCs proliferation at 48 and 72 h (Figure 1d),
likely suggesting an additive effect of EMF on SCs proliferation.
This effect was not dependent on a decrease in cell death. Indeed,
EMF did not induce any sign of cell death or changes in cells
viability at all time points considered, even after a double
exposure (Figure 1e). However, the effect observed appeared cell
speciﬁc, since proliferation of SaOS-2 cell (osteosarcoma) was not
affected by EMF exposure (Supplementary Figure S1). Taken
together, these ﬁndings suggested a SCs shift toward an
undifferentiated state, mainly attributable to an altered control
of cell proliferation.
SCs exposed to EMFs possess greater migratory and chemotactic
capabilities
We used a wound-healing assay, performed on a cell monolayer,
and Boyden chamber assay to measure motility. We found that
EMF exposure promoted the SC motility. Indeed, a great number
of SCs were able to repopulate the wounded region within 24 h,
achieving a complete closure of the two sides at later times, 48
and 72 h (Figure 2a). EMF exposure induced a signiﬁcant increase
(Po0.05) in SC motility at 6 and 24 h, corroborating the EMF
effect on cell migration. The concomitant presence of mitomycin
50 ng/ml excluded any proliferative component on the gap
closure observed (Figure 2b). The effect was signiﬁcantly counter-
acted (Po0.05) by a pre-treatment with cyclodextrin 5 mM
(Figure 2c), a molecule used to produce changes in membrane
cholesterol,22 thus indicating that a disorganization in lipid rafts
and cell membrane architecture may alter the SC migratory
Figure 1. SCs change morphology and proliferation following EMF exposure. (a) Merge image of SC characterized by immunopositivity for P0
and S100 markers, respectively (anti-P0-594, in red; anti-s100-488, in green), showing a cell purity more than 98%. Nuclei were stained with
DAPI, in blue. Scale bar 10 μm. (b) Scheme of the experimental model used. SCs were exposed to EMF of 50 Hz, 0.1 T, for 10min, then cells
were assayed for proliferation, migration, vitality, chemoresponsivity, morphology, western blot, qRT-PCR and RT2 proﬁler PCR. (c) EMF
exposure induces SCs morphologic rearrangements in actin cytoskeleton, as assessed by immunopositivity for f-actin (phalloidin-FICT, in
green). SCs turned from a spindle-shaped to an enlarged phenotype, suggesting alterations in the differentiation program. Nuclei were
stained with DAPI, in blue. Scale bar 10 μm. (d) SCs proliferation was assessed at 6, 24, 48 and 72 h, following a single (dashed line) or double
(dot line) EMF exposure. EMFs produced a signiﬁcant (*Po0.05) increase in cell proliferation. Experiments were repeated at least three times
and data expressed as cell number (×103). Two-way ANOVA using Bonferroni’s post hoc test was used for statistical analysis. (e) Percentage of
SCs vitality was assessed at 6, 24, 48 and 72 h, following a single (white columns) or double (gray columns) EMF exposure, but no signiﬁcant
changes in SCs vitality were observed. Controls (CONTR, black columns). The values are means± S.D. (N= 3).
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response to the EMF. This is in accordance with the morphologic
rearrangement in actin cytoskeleton seen in Figure 1c.
We next measured the SCs chemotactic response by mean of
Boyden chamber assay. We found that EMF-exposed SCs were more
responsive to a chemotactic agent, such as the fetal calf serum (FCS;
Figure 2d). The co-treatment with 5mM cyclodextrin abolished the
chemotactic migration to the control levels. This effect strongly
suggested the hypothesis that an autocrine factor, tightly interacting
with the cell membrane, may regulate the SCs development, then
addressing their fate toward a proliferative state and in turn
changing their migration and chemotactic responsiveness.
Expression of myelin proteins P0 and peripheral myelin protein of
22 kDa (PMP22) is changed in EMF-exposed SCs
As expected, the increase in proliferation/migration observed was
associated with a decrease in myelinating parameters. Overall,
the gene expression of two characteristic myelin proteins of the
peripheral nervous system (PNS), the glycoprotein P0 and the
PMP22, signiﬁcantly dropped down (at least Po0.05) in SCs
exposed to EMF at 2, 6 and 24 h (Figure 3a). In accordance, also the
protein levels were signiﬁcantly downregulated (Po0.05), whereas
the effects were sharp at later times, 6 and 24 h post exposure
(Figure 3b). Overall, the effects seemed to be larger for PMP22.
Merlin levels are decreased in SCs exposed to EMFs
Changes in the tumor suppressor merlin are predictive of
oncogenic tranformations in SCs. As expected, 2 h after EMF
exposure the quantitative real-time PCR (qRT-PCR) analysis
revealed a signiﬁcant 25% decrease in merlin gene expression
after treatment (compared to control; Po0.05); this primer effect
was not evident at later time points (Figure 3c). In accordance,
merlin protein levels were equally downregulated in SCs, as
shown by the immunoblot in Figure 3d. Quantitative data
conﬁrmed a signiﬁcant 25% downregulation (Po0.05) of merlin
protein levels 2 h after EMF exposure, while no changes were
observed at later time points (Figure 3d). Loss of merlin gene has
been associated with defects of SC bipolar extension,23 in
accordance with the enlarged SC morphologic phenotype
observed (Figure 1b). However, the lower merlin levels showed
a different cellular distribution (Figure 3e), because in the SCs
exposed to the EMF merlin appeared more localized in the
cytoplasm rather than in the nucleus (controls). Such an effect
corroborated the loss of merlin suppressor function, which
necessarily would occur through a nuclear localization.
ERK and AKT signaling pathways are activated in SCs following
EMF exposure
Then we investigated the pathways involved in the SCs
transformation and proliferation outcomes reported above. We
found that both ERK (Ras/Raf/Mek/Erk) and AKT (PI3K/AKT)
signaling pathways, which modulate biochemical pathways
controlling cell growth and apoptosis, were activated. Quantitative
immunoblots analysis conﬁrmed that pERK signiﬁcantly rose at 2 h
(Po0.001), then signiﬁcantly decreased at 6 h (Po0.001); tERK
Figure 2. SCs migration and chemoresponsivity are increased following 10min EMF exposure. (a) Microscopic images of SCs cultures, exposed
to EMF, in which a scratch has been done on the bottom of the well (t0). Medium was replaced and cell proliferation was blocked by adding
50 ng/ml mitomycin. SCs migrate after 2 (t2) and 6 (t6) h, closing the wound region within 24 h (t24). A complete closure was seen at 48 (t48)
and 72 (t72) h. Scale bar 10 μm. (b) Histograms of cell distance (μm) of SCs exposed to 10min EMF (EMF, white columns) versus controls
(CONTR, black columns). EMFs produced a signiﬁcant (*Po0.05) increase in cell migration at 6 and 24 h. The distance (μm) was calculated as
difference between measurements of empty space at time 0 and following time points (2, 6 and 24 h). The values are means± S.D. (N= 3).
(c) Distance (μm) of SCs exposed for 6 h to 10min EMF was signiﬁcantly counterbalanced (*Po0.05) by pre-treatment with cyclodextrin 5 mM
(EMF+CDX, white column). Experiments and data were calculated versus controls (CONTR, black columns), as above. The values are means± S.D.
(N= 3). (d) A 10-min EMF exposure make the SCs signiﬁcantly (*Po0.05) responsive to the chemotactic agent FCS 1%. Migrating cell number
(per well) of SCs exposed (EMF, white column) was calculated after 6 h, versus controls (CONTR, black columns). SCs co-treated with 5 mM
cyclodextrin reversed the chemotactic response to the control levels (diagonal lines column). The values are means± S.D. (N= 3). One-way
ANOVA using Tukey's post-test was used for all statistical analysis.
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Figure 3. Myelin proteins (P0 and PMP22) and Nf2/merlin are decreased following 10min EMF exposure. (a) Relative quantiﬁcation by qRT-PCR
of mRNA levels, coding for proteins P0 and PMP22 respectively, showed a decreased expression at all time points considered, 2, 6 and 24 h.
Data were normalized to the housekeeping genes α-tubulin and β2-microglobulin and expressed as difference (ΔΔCt) versus controls, then
averaged for each experimental group. The columns control (CONTR, black) and EMF-exposed SC (EMF, white) were expressed as fold changes.
The values are means± S.D. (N= 3). *Po0.05, **Po0.01, ***Po0.001. (b) Western blot analysis corroborated the decrease of P0 and PMP22 in
EMF-exposed SCs (EMF, white columns), with signiﬁcant effects at later times, 6 and 24 h (*Po0.05). Data were normalized for α-tubulin, were
expressed as percentage versus controls (CONTR, black columns). The values are means± S.D. (N= 3). (c) Neuroﬁbromin 2 (Nf2) mRNA levels
were assayed by qRT-PCR, showing a signiﬁcant decrease (*Po0.05) 2 h after EMF exposure. Data normalized to α-tubulin and
β2-microglobulin were expressed as difference (ΔΔCt) versus controls, then averaged for each experimental group. The columns control
(CONTR, black) and EMF-exposed SC (EMF, white) were expressed as fold changes. The values are means± S.D. (N= 3). (d) Accordingly, also the
Nf2 protein levels were decreased 2 h following EMF exposure. Qualitative immunoblot (left panel) showing that the speciﬁc band for Nf2
(70 KDa) was downregulated in SCs. The α-tubulin (50 KDa) was used as a housekeeping protein. Quantitative data (right panel) conﬁrmed a
signiﬁcant downregulation of Nf2/merlin at 2 h (*Po0.05, white columns), while no changes were observed at 6 and 24 h. Experiments were
normalized for α -tubulin, and expressed as percentage versus controls (CONTR, black columns). The values are means± S.D. (N= 3). One-way
ANOVA using Tukey's post-test was used for all statistical analysis. (e) Confocal images showed a different cellular distribution of Nf2/merlin.
SCs were immunopositive for the speciﬁc markers P0 (red) and Nf2 (green). Merge images (yellow) revealed that merlin was more localized in
the cytoplasm of EMF-exposed SCs, rather than in the nucleus (CONTR). Scale bar 10 μm.
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Figure 4. ERK and AKT signaling pathways are activated in SCs following 10min EMF exposure. (a) Representative immunoblots showing the
variations in phosphorylated ERK 2 (pERK 2), total ERK 2 (tERK 2), both 42 KDa, phosphorylated AKT (pAKT), total AKT (tAKT), both 60 KDa, in
SCs at 2 and 6 h following EMF exposure. The β-actin (43 KDa) was used as a housekeeping protein. (b) Quantitative data at 2 h showed that
pERK levels signiﬁcantly increased (***Po0.001), while tERK levels decreased (*Po0.05); the pERK/tERK ratio showed that ERK signaling was
activated 2 h following EMF exposure (***Po0.001, white columns). Indeed, pERK levels signiﬁcantly decreased at 6 h (***Po0.001), while
tERK signiﬁcantly increased at 6 h (***Po0.001); pERK/tERK ratio indicated that this signaling pathway was deactivated within 6 h following
EMF exposure (***Po0.001). Experiments were normalized for β-actin, and expressed as percentage versus controls (CONTR, black columns).
The values are means± S.D. (N= 3). (c) Quantitative data at 2 h showing that pAKT levels signiﬁcantly increased (***Po0.001), while tAKT
levels were unchanged; the pAKT/tAKT ratio showed an activation trend, even not signiﬁcant. At 6 h, pAKT levels did not change but tAKT
levels were signiﬁcantly rised (***Po0.001); pAKT/tAKT ratio revealed a signiﬁcant deactivation within 6 h after EMF exposure (***Po0.001,
white columns). Experiments were normalized for β-actin, and expressed as percentage versus controls (CONTR, black columns). The values are
means± S.D. (N= 3). One-way ANOVA using Tukey's post-test was used for all statistical analysis.
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levels, indeed, showed a light but signiﬁcant decrease at 2 h
(Po0.05), then a signiﬁcant increase at 6 h (Po0.001; Figure 4b).
Analysis of pERK/tERK ratio conﬁrmed that ERK signaling was
activated at short time (2 h), and deactivated within 6 h after EMF
exposure (Po0.001; Figure 4b).
AKT analysis showed a similar signaling proﬁle. Quantitative
immunoblots analysis conﬁrmed pAKT signiﬁcant increase at 2 h
(Po0.001), without changes 6 h after EMF exposure; tAKT levels were
signiﬁcantly augmented only 6 h after EMF exposure (Po0.001;
Figure 4c). Analysis of pAKT/tAKT ratio showed a trend of AKT
activation (even not signiﬁcant) at short time (2 h), and AKT signiﬁcant
deactivation within 6 h after EMF exposure (Po0.001; Figure 4c).
Taken together these data corroborate an early activation
of both signaling pathways, ERK and AKT, in controlling SCs
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proliferation 2 h following EMF exposure. Both signaling pathways
were turned off within 6 h following EMF exposure.
Dysregulation of the Hippo signaling pathway is a consequence of
EMF exposure
The RT2 proﬁler PCR array was then performed to study also the
possible involvement of Hippo pathway in SCs exposed to EMF.
Overall, at least 21 genes that are upstream or downstream
mediators of Hippo pathway were found to be changed.
Bioinformatic analysis, however, revealed a downregulation of
some of these genes, differently involved in the whole Hippo
pathway (Figure 5a). In detail, some proteins especially involved in
cell polarity, such as Amotl2 (angiomotin like-2 protein) and Crb
(Crumbs homolog) protein complex (including proteins 1, 2 and 3),
showed a decrease in gene expression (Figure 5b). As expected,
merlin (Nf2) expression was decreased, in accordance with qRT-PCR
and immunoblot results previously performed (Figures 3c and d).
Other proteins, such as Dchs (dachsous protein, a member of
transmembrane proteins belonging to the cadherin superfamily),
Fat (transmembrane cadherin proteins) or Wnt1 (proto-oncogen
protein1), involved in cell adhesion and myelinogenesis respectively,
were also found to be changed (Figure 5b).
Based on these results, we focused our attention on some of
these genes. In particular, we were interested in Amotl2 and Crb
(1, 2, 3) two proteins involved in cell morphologic rearrangements
and polarity changes, as part of the tight-junction complex.
Validation by qRT-PCR of the analysis previously performed in SC
conﬁrmed a signiﬁcant downregulation (at least Po0.05) of
their expressions following EMF exposure (Figure 5c). Then we
analyzed the transcriptional co-activator Yap1, which is a
downstream effector of Hippo pathway related to Crb/Amotl
tight junction.8 The qRT-PCR analysis conﬁrmed a signiﬁcant
downregulation (Po0.001) of Yap1 in SCs after EMF exposure
(Figure 5d). Interestingly, Yap1 cellular localization was also
changed. In control, SCs Yap1 was mainly localized in the
nucleus, supporting its physiologic activity in controlling
proliferation and apoptosis,8 while in exposed SCs its nuclear
localization was decreased, being Yap1 mostly present in the
cytoplasm (Figure 5e). In accordance, the absence of apoptosis in
EMF-exposed SCs was strengthened by the lack of characteristic
apoptotic nuclei, as observed by immunoﬂuorescence analysis
(see details in Figure 5e).
Taken together our ﬁndings, obtained by independent
methods that consider different targets and mediators,
supported the Hippo pathway involvement downstream to the
merlin changes in SCs. This may be responsible of the
Yap-mediated anti-apoptotic and proliferative effects observed
on SCs (Figure 5f).
DISCUSSION
Our ﬁndings show that the tumor suppressor Nf2/merlin is
downregulated in SCs exposed to EMFs, resulting in altered
morphology, proliferation, migration and SCs myelinating cap-
ability. All of these ﬁndings are associated with a consistent
modulation of ERK/AKT and Hippo signaling pathways.
These conclusions are based on some observational changes in
SCs phenotype. We found that SCs change their shape from
spindle-shaped to an enlarged morphology (Figure 1b), suggest-
ing that EMFs alter the differentiation program.
It is known that during differentiation SCs switch from ﬂat into a
spindle-shaped phenotype, which presents a re-organization of
f-actin cytoskeleton and the appearance of the stress ﬁber
bundles.24 SCs assuming the bipolar-shaped morphology resem-
ble the cells starting the myelination process in vivo.24,25 There-
fore, our morphologic changes point to a SC de-differentiation
process. Notably, this phenomenon matches with a speciﬁc
increase in cell proliferation (Figure 1d). It has been hypothesized
that an autocrine growth factor and/or the translocation/recycling
of membrane receptors may be responsible for the SC prolifera-
tion changes. Interestingly, the transport to the plasma membrane
of the γ-aminobutyric type B1 (GABA-B1) receptor and the
neuronal excitatory amino acid transporter EAAC1/EAAT3, which
localize in the elongated SC tips, appears to be associated with
cytoskeleton rearrangements required for the GABAergic func-
tions in SCs.25,26 However, changes in proliferation, but not in
survival, were found also in other cell systems, presumably due to
growth factors such as FGF-1 or IL-227,28, as well as to cellular
signaling factors such as ErbB4.29
The balance between proliferating and myelinating challenges
in SCs may regulate their development toward the myelinating
and/or the non-myelinating phenotype.30,31 In this light, an
increase in proliferation/migration should correspond to a
decrease in myelinating parameters. The changes in P0 and
PMP22 protein expressions shown herein are in line with this
hypothesis (Figures 3a and b). Moreover, the decrease in the
proto-oncogen protein Wnt1 (Figure 5b) ﬁts with the diminished
P0 and PMP22 levels,32 corroborating the reversion in the
myelinating program in the SC exposed to the EMF.
The analysis of expression and phosphorylation of ERK and AKT
revealed an activation of this pathways (Figure 4), raising the
Figure 5. Hippo and Yap1 are altered in SCs at 2 h following EMF exposure. (a) Overview of the scatter plot of expression of 84 genes, related
to the Hippo pathway, in which at least 21 genes were found to be changed (downregulated, green dots) in EMF-exposed SCs, versus controls
(CONTR). The black line indicates fold changes (2−ΔΔCt) of 1.The dot lines indicate the desired fold change in gene expression threshold.
Experiments were repeated at least three times, and normalized for β-actin (Actb), lactate dehydrogenase A (Ldha) and the 60S acidic
ribosomal protein P1 (Rplp1). (b) Scheme of hierarchical clustering of normalized genes examined by RT2 proﬁler PCR array. Some genes
coding for proteins involved in cell polarity, such as angiomotin like-2 protein (Amotl2) and Crumbs homolog proteins 1, 2 and 3 (Crb1, Crb2
and Crb3 respectively), as well as proteins involved in cell adhesion and myelinogenesis, such as dachsous proteins (Dchs), transmembrane
cadherin proteins (Fat) or proto-oncogen protein1 (Wnt1), showed a decreased expression following EMF exposure (green square), versus
controls (CONTR, red square). Also Yes-associated protein 1 (Yap1) was found to be downregulated. (c) Amotl2, Crb1, 2 and 3 gene expressions
quantiﬁcation was done by qRT-PCR, conﬁrming a signiﬁcant expression decrease following EMF exposure. Data were normalized to the
housekeeping genes β-actin and Ldha, and expressed as difference (ΔΔCt) versus controls, then averaged for each experimental group. The
columns control (CONTR, black) and EMF-exposed SC (EMF, white) were expressed as fold changes. The values are means± S.D. (N= 3).
One-way ANOVA using Tukey's post-test was used for statistical analysis. *Po0.05, **Po0.01. (d) Also Yap1 gene expressions quantiﬁcation by
qRT-PCR conﬁrmed a signiﬁcant decrease (***Po0.001) following EMF exposure. Data were normalized, calculated and repeated as described
above. Control (CONTR, black column) and EMF-exposed SC (EMF, white column) were expressed as fold changes (means± S.D.; N= 3).
(e) Confocal images showed a different cellular distribution of Nf2/merlin. SCs were immunopositive for the speciﬁc markers P0 (red) and Nf2
(green). Merge images (yellow) revealed that merlin was mostly localized in the cytoplasm of EMF-exposed SCs, rather than in the nucleus
(CONTR). Scale bar 10 μm. (f) Model of the Hippo/Yap pathway involvement. In control SCs, Yap functions as tumor suppressor, assembling
with Amotl2, Crb and merlin to maintain the tight junctions. In EMF-exposed SCs, the tight-junction complex is disassembled and Yap is more
localized in the cytoplasm.
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possibility that EMF affects SC proliferation via mechanisms
involving the ERK/AKT signaling pathways. This possibility is in
agreement with previous observations obtained in schwannomas
cells, in which merlin is lost while the ERK pathway is activated.33
Merlin is an important tumor suppressor factor, acting at the
cell-to-cell tight junctions to ensure contact inhibition of growth,
thus repressing proliferation.34 Merlin was proved to inhibit
mitogenic signaling by interacting with different target effectors
at the cell membrane surface.35,36 The EMF ability to alter
membrane integrity37 may cause tight-junctions remodeling,
inducing mitogenic signals via ERK. The reduced levels of Crb
and Amotl (Figures 5b and c) suggest an impairment in tight-
junction protein complex stability, entailing a dissociation of the
Amotl/merlin complex (Figure 5f). If this holds true, then we
suggest that merlin relocates to the cytoplasm (Figure 5e), likely
promoting ERK activation and cell proliferation, as demonstrated
by others.34,38 Altogether, these ﬁndings suggest that the tight
junctions are an important target altered in EMF-exposed SCs,
then leading to the loss of adhesion properties and to the increase
in migrating capability (Figure 2). This is supported by the
evidence that a disorganization in the cell membrane architecture
abolishes the EMF effects on SCs migration (Figures 2c and d).
Therefore, in line with the increased migrating capability in SCs,
the decreased levels of merlin may be predictive of the oncogenic
transformation.
Several lines of evidence from the literature indicate that the
Hippo pathway is critical for the regulation of the tight-junction
complex.37 Interestingly, in our study we also found an important
modulation of the Hippo/Yap pathway in SCs, which contributes
to the tight-junction complex and, when activated, it serves as
tumor suppressor to limit cell growth. The dysregulation of the
Hippo downstream effector Yap, that we found downregulated in
our experiments (Figure 5d), produces an increased cell prolifera-
tion and decreased differentiation,8 in line with our ﬁndings. It is
also important to underline that AKT promotes Yap cytosolic
localization, resulting in its loss from the nucleus.39 Interestingly, in
our experiments we found increased AKT levels associated with
higher Yap immunopositivity in the cytoplasm (Figure 5e).
In conclusion, here we show a coordinated series of changes
(i.e., tight-junction alterations, merlin decrease, SC migration,
chemoresponsivity increase, Yap downregulation and redistribu-
tion), all converging into determining a reduction of the Hippo
pathway involvement in the control of SCs fate following 50 Hz
EMF exposure (see Figure 6). Notably, the reduction of the
oncosuppressor properties in the SCs, resulting in an altered
differentiation program, may be, at least in theory, pathologically
relevant for the schwannoma transformation. The identiﬁcation of
such altered mechanisms opens new questions on the exposure
of SCs to the EMFs, although the ﬁne identiﬁcation of the
intracellular signaling involved deserves further investigation. It is
important to note that even though the therapeutic use of low-
frequency (20 Hz) EMFs has long been proposed to promote
peripheral nerve regeneration,19–21 the 50 Hz frequency (applied
in our experiments) is commonly used in several medical devices
for magnetotheraphy,40,41 and in other electric devices. We
suggest that when SCs are altered by EMF exposure, the risk to
develop a neuroﬁbroma may rise. Although the increased risk of
vestibular schwannomas, coming from the long-term use of
wireless phones, is still debated and needs further investigations,
data from clinical case–control studies corroborate this patho-
genic correlation15–18 and open new questions that need to be
resolved.
MATERIALS AND METHODS
Cell cultures
SC cultures were obtained by the method of Brockes26 with minor
modiﬁcations.27 Sciatic nerves from 3-day-old rats were digested with 1%
collagenase and 0.25% trypsin (Sigma, Milano, Italy), then cell pellets were
suspended in Dulbecco's modiﬁed Eagle's medium (DMEM, Serotec,
Oxford, UK), supplemented with 10% FCS (Gibco-Life Technologies, Monza,
Italy) and plated onto 35mm Petri dishes. Twenty-four hours after plating,
the medium was added with 10 μM arabinoside C (Sigma), then after 48 h
the cultures were treated with a stream of cold DMEM-FCS 10%.
Immunopanning for ﬁnal puriﬁcation was carried out with mouse anti-
rat -Thy1.1 antibody (Serotec, Oxford, UK) followed by 500 μl of baby rabbit
complement (Cedarlane, Burlington, ON, Canada). Cell suspension was
seeded on 60mm Petri dishes or multiwells, maintained in DMEM, 10%
FCS, 2 μM forskolin, 200 μg/ml bovine pituitary extract (BPE, Invitrogen,
Monza, Italy). At third in vitro passage, SCs were treated for 48 h with 4 μM
forskolin, then used for different assays. SaOS-2 is a mature osteoblastic
cell line derived from a human osteosarcoma. These cells were obtained
from the American Type Culture Collection (Manassas, VA, USA) and
routinely grown at 37 °C (5% CO2 and 95% air), in DMEM supplemented
with 10% FCS, 2 mM glutamine, 100 IU/ml penicillin, 100 μg/ml strepto-
mycin and 1mM sodium pyruvate.
EMF treatment
SCs were plated and treated with EMF at 50 Hz and 0.1 Tesla (T) for 10min
at 37 °C, then were used at different time points, according to the speciﬁc
experimental assays. SCs used as control were plated in same culture
conditions, without EMF exposure.
Proliferation assay
Proliferation assay on SCs was performed using an automated cell counter
(Luna; Logos Biosystems Inc, Annandale, VA, USA); 10 000 cells were plated
into 35mm petri dishes and collected after 6, 24, 48 and 72 h, with Trypsin
0.05%-EDTA 0.02% in phosphate buffer solution (PBS, Euroclone, Pero,
Italy). The cells suspended in DMEM were then counted with the vital stain
Trypan Blue (Logos Biosystems), which stains only death cells. SaOS-2 cell
proliferation was evaluated using the automated Luna cell counter (as
above) and by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide) assay. Cells were seeded in 35mm Petri dishes for 2 and
24 h, then stained with MTT solution (0.5 mg/ml) for 30min at 37 °C.
Absorbance was measured at 570 nm. Each experimental point was in
quadruplicate and experiments replicated at least three times.
Migration and chemotaxis assays
Wound healing assay was performed by making a scratch on the bottom
of the petri, then the medium was changed with fresh medium plus
mitomycin 50 ng/ml (Sigma) to counteract cell proliferation and the cells
exposed to EMF. Some samples were also pre-treated with cyclodextrin
5mM 30min before EMF exposure. Cells were then photographed with a
scanning microscope (Axiovert 200 Zeiss, Jena, Germany) at different time
points: 2, 6, 24, 48 and 72 h after the scratch. Pictures were acquired using
Figure 6. Scheme of the effects occurring in SCs following 10min
EMF exposure. The SCs that were exposed to a high-frequency
(50 Hz, 0.1 T) EMF change some biological processes, mainly
increasing proliferation and migration; they become more respon-
sive to chemoattractants (see Results). Contemporarily, SCs decrease
their oncosuppressor characteristic, because their levels of the
oncosuppressor Nf2/merlin resulted downregulated and differently
distributed (see Results). By this way, SCs alter their differentiation
program, becoming, in principle, pathologically relevant for
schwannoma development.
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MetaVue software (Molecular Devices, Sunnyvale, CA, USA) and the
distances between cell fronts were measured with Image-ProPlus 6.0
(MediaCybernetics, Bethesda, MA, USA), considering at least nine
measurements from the top to the bottom. Migration was also tested by
Boyden assay (chemotaxis) using a 48-well Boyden's chamber, according
to the manufacturer's instructions (Neuroprobe, Cabin John, MD, USA).
Cells were exposed to EMF as described above, also in the presence of
cyclodextrin 5mM. In all, 28 μl of control medium (DMEM) or DMEM/FCS
1% was placed in the lower compartment of the chamber, as chemo-
attractants. The open-bottom wells of the upper compartment were ﬁlled
with cells (105 cells/well), collected by trypsin and suspended in DMEM
+0.1% bovine serum albumin (BSA, Sigma). Cells migrate through a
polyvinylpyrrolidone-free polycarbonate porous membrane (8 μm pores)
pre-coated with gelatine (0.2 mg/ml in PBS, 5 days at 4 °C). After migration
(overnight, 37 °C), cells adherent to the underside of the membrane were
ﬁxed by methanol and stained according to the Diff-Quik kit (Biomap,
Milan, Italy). For quantitative analysis, cells were observed and counted
using a × 40 objective on an optical microscope. Three random objective
ﬁelds were counted for each well and the mean number of migrating cells
was calculated.
Immunoﬂuorescence and confocal scanner laser microscopy
Cells were seeded on slides, then ﬁxed in 4% paraformaldehyde (PFA), and
processed for immunostaining. The SC purity (more than 98%) was tested
with a speciﬁc antibody against glycoprotein P0.27 Phalloidin-FITC staining
of f-actin (1 : 250, Sigma) was used to reveal SC cytoskeleton. Slides were
incubated overnight at 4 °C in PBS, 0.25% BSA, 0.1% Triton X-100 and the
speciﬁc primary antibody. The primary antibodies used in this experiments
were the following: speciﬁc antibody against glycoprotein P027 (1 : 200)
and S100 protein (1 : 200, Sigma) to assess the SCs purity (498%); to reveal
SC cytoskeleton was used phalloidin-FITC to stain f-actin (1 : 250, Sigma)
and anti-Nf2 (1: 500, Santa Cruz Biotechnology Inc, Dallas, TX, USA). The
following day, the slides were washed two times and incubated 2 h at
room temperature with Alexa-488 (green) or Alexa-594 (red) speciﬁc
secondary antibody (1 : 800, Gibco-Life Technologies). After washing, slides
were mounted using Vectashield (Vector Laboratories, Burlingame, CA,
USA) and nuclei stained with 4,6-diamidino-2-phenylindole (DAPI).
Controls for the speciﬁcity of antibodies included a lack of primary
antibodies. Confocal microscopy was carried out using a Zeiss LSM 510
System (Gottingen, Germany) and images were processed with Image Pro-
Plus 6.0.
RNA extraction and qRT-PCR
RNA samples were extracted with using Trizol (Gibco-Life Technologies)
according to the manufacturer’s protocol, then quantiﬁed with Nano-
Drop2000 (Thermo Scientiﬁc, Waltham, MA, USA). Pure RNA was obtained
after DNAse treatment with a speciﬁc kit (Sigma). The retro-transcription
reaction was carried with RT Iscript Supermix 5x (Bio-Rad, Segrate, Italy) on
1 μg of puriﬁed RNA and the product was used to make qRT-PCR assay.
Primers were designed by QuantPrime software (AG Bioinformatics Max-
Planck, Postdam, Germany). The following primers were used: P0: 5′-CCTGC
TCTTCTCTTCTTTG-3′ and 5′-CACAGCACCATAGACTTC-3′; PMP22: 5′-TCCTGT
TCCTTCACATCG-3′ and 5′-TGCCAGAGATCAGTCCTG-3′; Nf2: 5′-ACGATGGCC
AATGAAGCTCTGATG-3′ and 5′-TGGCCTTGATTCGCTGCATCTC-3′; α-tubulin:
5′-TCGCGCTGTAAGAAGCAACACC-3′ and 5′-GGAGATACACTCACGCATGGT
TGC-3′; β2-microglobulin: 5′-TGCTTGCAGAGTTAAACACGTCAC-3′ and 5′-TTAC
ATGTCTCGGTCCCAGGTG-3′; α-tubulin and β2-microglobulin were used as
housekeepers. qRT-PCR was performed by measuring the incorporation of
SYBR Green dye (Bio-Rad) on CFX 96 Real Time System-C1000 touch thermal
cycler (Bio-Rad). Data analysis was performed using the CFX Manager 2.0
software (Bio-Rad), based on ΔΔCt method for the relative quantiﬁcation.
The threshold cycle number (Ct) values of both the calibrator and the
samples of interest were normalized to the Ct of the endogenous
housekeeping genes. As calibrator we used the RNA obtained from control
samples.
Expression proﬁle of Hippo pathway
The Rat Hippo signaling pathway RT2 Proﬁler PCR arrays (SuperArray
Bioscience, Qiagen, Valencia, CA, USA) were used to proﬁle the expression
of 84 genes related to Hippo signaling pathway. Total RNA was extracted
from SCs, 2 h after treatment, as above, and their controls with the same
method. Single-stranded cDNA was synthesized from 2 μg of total RNA by
using the SuperArray reaction ready ﬁrst-strand cDNA synthesis kit.
The cDNAs were mixed with SuperArray RT2 Real time SYBR Green/ROX
PCR master mix and real-time PCR performed in accordance with the
manufacturer’s instructions. Thermal cycling and ﬂuorescence detection
were performed using an ABI Prism 7700 Sequence Detection System
(Applied Biosystems, Monza, Italy), then the expression of Hippo signaling
regulated transcripts was compared between groups.
Western blot
Protein samples were extracted in lysis buffer (PBS, 1% Nonidet P-40 and
1mM EDTA; all from Sigma) containing a cocktail of protease inhibitors
(Sigma). Samples were heated 20min at 55 °C to denaturate secondary
structures, then 15 μg was loaded onto a SDS-PAGE gel (Criterion TGX,
Bio-Rad) and run at 200 V for 40min in running buffer. Gels were
electroblotted to Hybond nitrocellulose membrane (GE Healthcare, Milano,
Italy). Membranes were blocked with 5% not-fat dry milk (Bio-Rad) in PBS
(Euroclone) before incubation with the primary antibody diluted in the
blocking solution. Primary antibodies used were rabbit anti-P0 (1 : 300,
Sigma-Genosys, Spring, TX, USA), rabbit anti-PMP22 (1 : 300, Abcam,
Cambridge, UK), anti-Nf2 (1 : 100, Santa Cruz Biotech, Dallas, TX, USA)
and monoclonal anti-alpha-tubulin as reference (1 : 500, Sigma). To detect
ERK2 and AKT levels, 10 μg proteins were loaded and the antibodies
used were the following: anti-phospho-AKT Ser473 (1 : 1000, Cell
Signaling Technology, Danvers, MA, USA), anti-AKT (1 : 1000, Cell Signaling
Technology), anti-phospho-ERK2 Tyr185/187 (1 : 1000, Cell Signaling
Technology), anti-ERK2 (1 : 5000 Santa Cruz Biotechnology), anti-β-Actin
(1 : 10 000, Sigma-Aldrich, Milano, Italy). In this case, results were
standardized using β-actin as a reference. Membranes were incubated
with appropriated HRP-conjugated secondary antibodies (Millipore,
Temecula, CA, USA). Immunocomplexes were revealed by enhanced
chemiluminescence (ECL; GE Healthcare), visualized using the Chemidoc
MP Imaging System (Bio-Rad) and analyzed by the Image Lab software
(Bio-Rad).
Statistical analysis
Data were statistically evaluated by GraphPad Prism 4.00 (San Diego, CA,
USA). Statistical signiﬁcance between groups was determined by means of
an unpaired Student’s t-test, one-way ANOVA with Tukey's post-test, or by
two-way ANOVA using Bonferroni’s post hoc test. P-values o0.05 were
considered as signiﬁcant.
ABBREVIATIONS
Nf2, neuroﬁbromin type 2 gene; SC, Schwann cell; EMF,
electromagnetic ﬁeld; ERM, ezrin-radixin-moesin; Yap, Yes-associated
protein; P0, myelin protein zero; FCS, fetal calf serum; PNS, peripheral
nervous system; pERK, phosphorylated ERK; tERK, total ERK; pAKT,
phosphorylated AKT; tAKT, total AKT; Amotl2, angiomotin like-2 protein;
Crb, Crumbs homolog; Dchs, dachsous protein; Fat, transmembrane
cadherin proteins; Wnt1, proto-oncogen protein1; DMEM, Dulbecco's
modiﬁed Eagle's medium; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide; BPE, bovine pituitary extract; BSA, bovine serum
albumin; PBS, phosphate buffer solution; PFA, paraformaldehyde; DAPI,
4,6-diamidino-2-phenylindole.
ACKNOWLEDGEMENTS
This work was supported by the Association Francaise Contre Les Myopathies (AFM,
grant n. n° 16342/2012 to VM) and by institutional grants from Università degli Studi
di Milano (to AC).
COMPETING INTERESTS
The authors declare no conﬂict of interest.
REFERENCES
1 Carroll SL. Molecular mechanisms promoting the pathogenesis of Schwann cell
neoplasms. Acta Neuropathol 2012; 123: 321–348.
2 Evans DG. Neuroﬁbromatosis type 2 (NF2): a clinical and molecular review.
Orphanet J Rare Dis 2009; 4: 16.
3 Pastar Z, Lipozencic J, Budimcic D, Tomljanovic-Veselski M. Neuroﬁbromatosis--
review of the literature and case report. Acta Dermatovenerol Croat 2006; 14:
167–171.
Nf2 drives Schwann cell differentiation
A Colciago et al
9
© 2015 Cell Death Differentiation Association Cell Death Discovery (2015) 15021
4 Hadﬁeld KD, Smith MJ, Urquhart JE, Wallace AJ, Bowers NL, King AT et al. Rates of
loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic
vestibular schwannomas and schwannomatosis schwannomas. Oncogene 2010;
29: 6216–6221.
5 Hergovich A, Hemmings BA. Mammalian NDR/LATS protein kinases in hippo
tumor suppressor signaling. Biofactors 2009; 35: 338–345.
6 Zhou L, Hanemann CO. Merlin, a multi-suppressor from cell membrane to the
nucleus. FEBS Lett 2012; 586: 1403–1408.
7 Zhao B, Li L, Lei Q, Guan KL. The Hippo-YAP pathway in organ size control and
tumorigenesis: an updated version. Genes Dev 2010; 24: 862–874.
8 Plouffe SW, Hong AW, Guan KL. Disease implications of the Hippo/YAP pathway.
Trends Mol Med 2015; 21: 212–222.
9 Zhang N, Bai H, David KK, Dong J, Zheng Y, Cai J et al. The Merlin/NF2 tumor
suppressor functions through the YAP oncoprotein to regulate tissue homeostasis
in mammals. Dev Cell 2010; 19: 27–38.
10 Funk RH, Monsees TK. Effects of electromagnetic ﬁelds on cells: physiological and
therapeutical approaches and molecular mechanisms of interaction. A review.
Cells Tissues Organs 2006; 182: 59–78.
11 Kesari KK, Siddiqui MH, Meena R, Verma HN, Kumar S. Cell phone radiation
exposure on brain and associated biological systems. Indian J Exp Biol 2013; 51:
187–200.
12 Messerli MA, Graham DM. Extracellular electrical ﬁelds direct wound healing and
regeneration. Biol Bull 2011; 221: 79–92.
13 Gurler HS, Bilgici B, Akar AK, Tomak L, Bedir A. Increased DNA oxidation (8-OHdG)
and protein oxidation (AOPP) by low level electromagnetic ﬁeld (2.45 GHz) in rat
brain and protective effect of garlic. Int J Radiat Biol 2014; 90: 892–896.
14 Carpenter DO. Human disease resulting from exposure to electromagnetic ﬁelds.
Rev Environ Health 2013; 28: 159–172.
15 Hardell L, Carlberg M, Hansson Mild K. Pooled analysis of two case-control studies
on the use of cellular and cordless telephones and the risk of benign brain
tumours diagnosed during 1997-2003. Int J Oncol 2006; 28: 509–518.
16 Hardell L, Carlberg M, Hansson Mild K. Use of mobile phones and cordless
phones is associated with increased risk for glioma and acoustic neuroma.
Pathophysiology 2013; 20: 85–110.
17 Moon IS, Kim BG, Kim J, Lee JD, Lee WS. Association between vestibular
schwannomas and mobile phone use. Tumour Biol 2014; 35: 581–587.
18 INTERPHONE Study Group Acoustic neuroma risk in relation to mobile telephone
use: results of the INTERPHONE international case-control study. Cancer Epidemiol
2011; 35: 453–464.
19 Sisken BF, Kanje M, Lundborg G, Herbst E, Kurtz W. Stimulation of rat sciatic
nerve regeneration with pulsed electromagnetic ﬁelds. Brain Res 1989; 485:
309–316.
20 Kanje M, Rusovan A, Sisken B, Lundborg G. Pretreatment of rats with pulsed
electromagnetic ﬁelds enhances regeneration of the sciatic nerve. Bioelec-
tromagnetics 1993; 14: 353–359.
21 Sherafat MA, Heibatollahi M, Mongabadi S, Moradi F, Javan M, Ahmadiani A.
Electromagnetic ﬁeld stimulation potentiates endogenous myelin repair by
recruiting subventricular neural stem cells in an experimental model of white
matter demyelination. J Mol Neurosci 2012; 48: 144–153.
22 Zidovetzki R, Levitan I. Use of cyclodextrins to manipulate plasma membrane
cholesterol content: evidence, misconceptions and control strategies. Biochim
Biophys Acta 2007; 1768: 1311–1324.
23 Thaxton C, Bott M, Walker B, Sparrow NA, Lambert S, Fernandez-Valle C.
Schwannomin/merlin promotes Schwann cell elongation and inﬂuences myelin
segment length. Mol Cell Neurosci 2011; 47: 1–9.
24 Li Y, Gonzalez MI, Meinkoth JL, Field J, Kazanietz MG, Tennekoon GI.
Lysophosphatidic acid promotes survival and differentiation of rat Schwann cells.
J Biol Chem 2003; 278: 9585–9591.
25 Procacci P, Ballabio M, Castelnovo LF, Mantovani C, Magnaghi V. GABA-B
receptors in the PNS have a role in Schwann cells differentiation?. Front Cell
Neurosci 2012; 6: 68.
26 Perego C, Di Cairano ES, Ballabio M, Magnaghi V. Neurosteroid allopregnanolone
regulates EAAC1-mediated glutamate uptake and triggers actin changes in
Schwann cells. J Cell Physiol 2012; 227: 1740–1751.
27 Claude P, Parada IM, Gordon KA, D'Amore PA, Wagner JA. Acidic ﬁbroblast
growth factor stimulates adrenal chromafﬁn cells to proliferate and to
extend neurites, but is not a long-term survival factor. Neuron 1988; 1:
783–790.
28 Lord JD, McIntosh BC, Greenberg PD, Nelson BH. The IL-2 receptor promotes
proliferation, bcl-2 and bcl-x induction, but not cell viability through the adapter
molecule Shc. J Immunol 1998; 161: 4627–4633.
29 Kainulainen V, Sundvall M, Maatta JA, Santiestevan E, Klagsbrun M, Elenius K.
A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase
mediates proliferation but not survival or chemotaxis. J Biol Chem 2000; 275:
8641–8649.
30 Mirsky R, Woodhoo A, Parkinson DB, Arthur-Farraj P, Bhaskaran A, Jessen KR.
Novel signals controlling embryonic Schwann cell development, myelination and
dedifferentiation. J Peripher Nerv Syst 2008; 13: 122–135.
31 Roberts SA, Lloyd AC. Aspects of cell growth control illustrated by the
Schwann cell. Curr Opin Cell Biol 2012; 24: 852–857.
32 Tawk M, Makoukji J, Belle M, Fonte C, Trousson A, Hawkins T et al. Wnt/beta-
catenin signaling is an essential and direct driver of myelin gene expression and
myelinogenesis. J Neurosci 2011; 31: 3729–3742.
33 Pecina-Slaus N. Merlin, the NF2 gene product. Pathol Oncol Res 2013; 19:
365–373.
34 Das T, Safferling K, Rausch S, Grabe N, Boehm H, Spatz JP. A molecular
mechanotransduction pathway regulates collective migration of epithelial cells.
Nat Cell Biol 2015; 17: 276–287.
35 McClatchey AI, Giovannini M. Membrane organization and tumorigenesis--the
NF2 tumor suppressor, Merlin. Genes Dev 2005; 19: 2265–2277.
36 Lallemand D, Saint-Amaux AL, Giovannini M. Tumor-suppression functions of
merlin are independent of its role as an organizer of the actin cytoskeleton in
Schwann cells. J Cell Sci 2009; 122: 4141–4149.
37 Lacy-Hulbert A, Metcalfe JC, Hesketh R. Biological responses to
electromagnetic ﬁelds. FASEB J 1998; 12: 395–420.
38 Morrison H, Sperka T, Manent J, Giovannini M, Ponta H, Herrlich P.
Merlin/neuroﬁbromatosis type 2 suppresses growth by inhibiting the activation of
Ras and Rac. Cancer Res 2007; 67: 520–527.
39 Basu S, Totty NF, Irwin MS, Sudol M, Downward J. Akt phosphorylates the
Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of
p73-mediated apoptosis. Mol Cell 2003; 11: 11–23.
40 Yan JL, Zhou J, Ma HP, Ma XN, Gao YH, Shi WG et al. Pulsed electromagnetic ﬁelds
promote osteoblast mineralization and maturation needing the existence of
primary cilia. Mol Cell Endocrinol 2015; 404: 132–140.
41 Saliev T, Mustapova Z, Kulsharova G, Bulanin D, Mikhalovsky S. Therapeutic
potential of electromagnetic ﬁelds for tissue engineering and wound healing. Cell
Prolif 2014; 47: 485–493.
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated
otherwise in the credit line; if the material is not included under the Creative Commons
license, users will need to obtain permission from the license holder to reproduce the
material. To view a copy of this license, visit http://creativecommons.org/licenses/
by/4.0/
Supplementary Information accompanies the paper on the Cell Death Discovery website (http://www.nature.com/cddiscovery)
Nf2 drives Schwann cell differentiation
A Colciago et al
10
Cell Death Discovery (2015) 15021 © 2015 Cell Death Differentiation Association
